Xylem Inc.'s stock plummeted 5.06% during Tuesday's intraday session, reversing early gains following the release of its first-quarter 2026 results.

The water technology company reported adjusted earnings per share of $1.12, beating the consensus estimate of $1.08. However, the market reaction turned negative as revenue of $2.125 billion, while slightly above the $2.11 billion estimate, represented a decline of 5.8% from the year-ago period and fell significantly short of some analyst expectations which were as high as $2.37 billion. Furthermore, organic revenue growth was flat for the quarter.

Analysts pointed to high restructuring costs of $38 million, which aided the adjusted EPS beat, and noted ongoing softness in key segments such as Infrastructure and Applied Water, attributed to weakness in China and residential and industrial end markets. The negative sentiment was compounded by JPMorgan cutting its price target on Xylem to $140 from $160, despite maintaining an Overweight rating.